MHIET U.S. Subsidiary’s Franklin Plant Celebrates 10th Anniversary

TOKYO, Dec 8, 2025 – (JCN Newswire via SeaPRwire.com) – Mitsubishi Heavy Industries Engine & Turbocharger, Ltd. (MHIET), a part of Mitsubishi Heavy Industries (MHI) Group, held a ceremony on November 7 to commemorate the 10th anniversary of the opening of the Franklin, Indiana (USA) plant of Mitsubishi Turbocharger and Engine America, Inc. (MTEA), headquartered in Itasca, Illinois, MHIET’s production base for automotive turbochargers in …

Lexus World Premieres Lexus LFA Concept BEV Sports Car

Lexus LFA Concept TOKYO, Dec 5, 2025 – (JCN Newswire via SeaPRwire.com) – Lexus, today, world premiered the Lexus LFA Concept-a battery electric vehicle (BEV) sports car concept model. Born from the strong conviction of Toyota Motor Corporation (TMC) Chairman Akio Toyoda, aka Master Driver Morizo, that certain car-making techniques and skills must be preserved and passed on to the next generation, the Lexus LFA Concept …

TOYOTA GAZOO Racing World Premieres GR GT & GR GT3

Toyota City, Japan, Dec 5, 2025 – (JCN Newswire via SeaPRwire.com) – TOYOTA GAZOO Racing (TGR) today world premiered two new models-the GR GT and GR GT3-by publicly displaying under-development prototypes for the first time. GR GT3 (Prototype) and GR GT (Prototype) Two new, unveiled models strive to provide an ultimate driving experience by way of enhanced capabilities centered on three key elements: a low …

TOYOTA GAZOO Racing and Lexus Hold World Premiere of GR GT, GR GT3, and Lexus LFA Concept

Toyota City, Japan, Dec 5, 2025 – (JCN Newswire via SeaPRwire.com) – TOYOTA GAZOO Racing (TGR) and the Lexus brand held the world premiere today of TGR’s GR GT and GR GT3 and Lexus’ Lexus LFA Concept. Left: Lexus LFA Concept; Center: GR GT3 (Prototype); Right: GR GT (Prototype) Three models positioned as flagships in the manner of the Toyota 2000GT of yesteryear and the …

World’s First General Design Approval (GDA) for Developed Steel and Post-Weld Heat Treatment (PWHT) Exemption based on ECA for Low-pressure Liquefied CO2 Tank made of KF460 steel

TOKYO, Dec 5, 2025 – (JCN Newswire via SeaPRwire.com) – Mitsubishi Shipbuilding Co., Ltd. (Mitsubishi Shipbuilding), a part of Mitsubishi Heavy Industries (MHI) Group, and Nippon Steel Corporation (Nippon Steel) have applied Nippon Steel’s developed steel to the cargo tanks of low-pressure liquified CO2 (LCO2) carriers and have jointly developed the PWHT(*1)-exemption technology based on ECA(*2). Both companies have recently received the world’s first General …

Hitachi at CES 2026: Building a Harmonized Society Through Technology

Hitachi booth concept for CES 2026 TOKYO, Dec 4, 2025 – (JCN Newswire via SeaPRwire.com) – Hitachi, Ltd. (TSE:6501, “Hitachi”) today announced its exhibition plans for CES 2026, to be held January 6 to 9, where it will unveil innovative solutions and technology roadmaps for a harmonized society. For over a century, Hitachi has been at the forefront of social innovation, combining Information Technology (IT), Operational …

Fujitsu and Scaleway partner to accelerate European sustainable transformation and data sovereignty with FUJITSU-MONAKA CPU-based AI inference

Kawasaki, Japan and Paris, France, Dec 4, 2025 – (JCN Newswire via SeaPRwire.com) – Fujitsu Limited and Scaleway, the leading European public cloud provider for AI builders, today announced a strategic collaboration towards the establishment of a sustainable AI utilization environment that also ensures data sovereignty. By combining Fujitsu’s advanced processor development expertise with Scaleway’s European cloud infrastructure expertise, the two companies aim to evaluate new …

NEC Orchestrating Future Fund Invests in PopID, Inc. to Accelerate Global Expansion of Biometric Payment Solutions and Launch a Strategic Collaboration

TOKYO, Japan — Dec 4, 2025 – (JCN Newswire via SeaPRwire.com) – NEC Orchestrating Future Fund (*1), an ecosystem-based corporate venture capital (CVC) fund, has invested in PopID, Inc. (PopID), a U.S.-based provider of face authentication payment services. The investment strengthens NEC’s position in next-generation digital transactions by combining its world-leading biometric authentication technology with PopID’s rapidly growing payment platform. Together, NEC and PopID aim …

Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI(R) (lecanemab-irmb) Maintenance Treatment in Early Alzheimer’s Disease at CTAD 2025

TOKYO and CAMBRIDGE, Mass., Dec 4, 2025 – (JCN Newswire via SeaPRwire.com) –  Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the latest findings on time savings with continued treatment with humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody lecanemab (generic name, U.S. brand name LEQEMBI®)  were presented …

The 26th Hong Kong Forum marks successful completion

HONG KONG, December 3, 2025 – (ACN Newswire via SeaPRwire.com) – The 26th Hong Kong Forum, jointly organised by the Hong Kong Trade Development Council (HKTDC) and the Federation of Hong Kong Business Associations Worldwide, wrapped up after the successful two-day event attracted more than 320 representatives from Hong Kong business associations worldwide and business leaders from 33 countries and regions. This year’s Hong Kong Forum focused …

Anime Tokyo Station: Celebrating the 25th Anniversaries of Two Popular Anime with an Anniversary Joint Exhibition Starting November 15

TOKYO, Dec 3, 2025 – (JCN Newswire via SeaPRwire.com) – Anime Tokyo Station is an anime exhibition site focused on Japanese anime content, which has developed a devout fan base around the world. From November 15, 2025 to February 15, 2026, it will be holding the “Digimon Adventure 02” & “Magical DoReMi #” ANIME 25TH ANNIVERSARY JOINT EXHIBITION. A sneak preview was held for the press …

Eisai Presents New Data on Anti-Tau Antibody Etalanetug (E2814) at CTAD 2025

TOKYO, Dec 2, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito) today announced that new data on anti-tau antibody etalanetug (development code: E2814) was presented at the 18th Clinical Trials on Alzheimer’s Disease Conference (CTAD). Etalanetug is designed to bind to the microtubule-binding region (MTBR) of tau protein and prevent the seeding and propagation of tau pathology. Anti-tau …

NEC Launches AI Agent Service in Japan to Automate Procurement Negotiations Using AI

TOKYO, Dec 2, 2025 – (JCN Newswire via SeaPRwire.com) – NEC Corporation (NEC; TSE: 6701) will begin offering its “NEC AI Agent Service for Procurement Negotiations” in Japan starting this December. This service utilizes NEC’s proprietary AI technology, “Automated Negotiation AI,” to autonomously generate optimal transaction terms for procurement operations in the manufacturing industry and to negotiate with suppliers. This service automates complex delivery date and …

Fujitsu develops new technology to support human-robot collaboration

KAWASAKI, Japan, Dec 2, 2025 – (JCN Newswire via SeaPRwire.com) – Fujitsu today announced the development of a new technology to make collaboration between robots and humans easier, safer and more efficient. The spatial world model technology makes it possible for AI to predict the future behaviors and states of different actors and objects within a space, and facilitates smooth collaboration between humans and robots, …

Fujitsu establishes international consortium to tackle disinformation/misinformation and new AI risks

KAWASAKI, Japan, Dec 2, 2025 – (JCN Newswire via SeaPRwire.com) – Fujitsu Limited today announced the establishment of Frontria, an international consortium bringing together over 50 global organizations to collaboratively address the escalating challenges of AI-generated disinformation, misinformation, AI system vulnerabilities, and regulatory compliance. This initiative aims to foster a healthy and resilient digital society by pooling cutting-edge technologies and expertise to enhance information reliability …

Fujitsu achieves high-precision, long-duration molecular dynamics simulation for all-solid-state battery interphases with over 100,000 atoms

KAWASAKI, Japan, Dec 1, 2025 – (JCN Newswire via SeaPRwire.com) – Fujitsu today announced the successful development of a technology for molecular dynamics (MD) simulation that enables atomic-level structural analysis of the solid electrolyte interphase (SEI) [1] formation process in all-solid-state batteries. This process, previously difficult to analyze, significantly impacts battery performance. Fujitsu achieved this breakthrough by developing a neural network potential (NNP) [2] training …

Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials

KAWASAKI, Japan, Dec 1, 2025 – (JCN Newswire via SeaPRwire.com) – Fujitsu Limited today announced the development of a multi-AI agent collaboration technology that enables secure collaboration and swift response to changing circumstances among AI agents from different companies and vendors within a supply chain. Leveraging this technology, Fujitsu will start field trials in January 2026 to optimize the supply chain of Rohto Pharmaceutical Co., Ltd. …

Fujitsu launches ‘Fujitsu Accelerator Program for SPORTS’ to create new value through Sports x Technology

KAWASAKI, Japan, Dec 1, 2025 – (JCN Newswire via SeaPRwire.com) – Fujitsu today announced the launch of “Fujitsu Accelerator Program for SPORTS,” a global partner co-creation program aimed at fostering new innovation in the sports sector. Through Fujitsu Accelerator, Fujitsu collaborates with startups and other companies to create new businesses and solve challenges by leveraging cutting-edge technologies such as AI and quantum computing. This new program …

Eisai Submits New Drug Application for Subcutaneous Formulation of “LEQEMBI(R)” for the Treatment of Early Alzheimer’s Disease in Japan

TOKYO and CAMBRIDGE, Mass., Nov. 28, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that Eisai has filed a new drug application for “LEQEMBI(R)” (brand name, generic name: lecanemab) seeking approval for a subcutaneous formulation (subcutaneous autoinjector: SC-AI) as a new …

JFCR, NEC, and Taiho to Develop Cancer Vaccines Utilizing Whole-Genome Information

TOKYO, Nov 28, 2025 – (JCN Newswire via SeaPRwire.com) – The Japanese Foundation for Cancer Research (JFCR), NEC Corporation (NEC), and Taiho Pharmaceutical Co., Ltd. (Taiho) have signed a three-party joint research (Joint Research) agreement aimed at developing new cancer vaccines through the utilization of whole-genome information. This Joint Research project will be carried out as part of the Japan Agency for Medical Research and Development …